SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-052360
Filing Date
2022-04-28
Accepted
2022-04-28 16:50:49
Documents
3
Group Members
DANIEL EDWARD LLEWELLEN COOKSON

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2213368d2_sc13da.htm SC 13D/A 52340
2 EXHIBIT 99.2 tm2213368d2_ex99-2.htm EX-99.2 18986
3 GRAPHIC tm2213368d2_ex99-2img001.jpg GRAPHIC 3609
  Complete submission text file 0001104659-22-052360.txt   78072
Mailing Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4
Business Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4 (604) 678-1388
Zymeworks Inc. (Subject) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89971 | Film No.: 22867588
SIC: 2834 Pharmaceutical Preparations

Mailing Address OFFICE 2301, 23RD FLOOR API TRIO TOWER AL BARSHA 1 DUBAI C0 NA
Business Address OFFICE 2301, 23RD FLOOR API TRIO TOWER AL BARSHA 1 DUBAI C0 NA 00971555241459
All Blue Falcons FZE (Filed by) CIK: 0001925178 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A